Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems that deliver measurable operational improvements. At the same time, they must keep these systems safe, explainable, and aligned with human judgment. Errors in these contexts carry real human and economic consequences. In manufacturing, these…
This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Life sciences organizations stand at a paradoxical moment in AI adoption. The technology’s potential is visible in discovery,…
Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high as $2 billion per drug and are accompanied by protracted timelines of 10-15 years. Pharmaceutical companies are turning to AI to shorten discovery timelines while dramatically upholding rigorous standards. AI-driven approaches have demonstrated meaningful…
Generative AI has been accelerating transformation across the life sciences, leaving pharmaceutical companies and clinical research organizations facing a dual challenge: modernizing pharmacovigilance while maintaining uncompromising standards for patient safety, data integrity, and global regulatory compliance. This delicate balance is most critical in adverse event detection and signaling, where a single missed risk can trigger…
This interview evaluation is sponsored by Deloitte and was written, edited, and printed in alignment with our Emerj sponsored content guidelines. Learn extra about our thought management and content material creation providers on our Emerj Media Services page. In R&D-intensive sectors akin to life sciences, agriculture, and superior supplies, a well-recognized problem persists: fragmented information…
Roche Diagnostics is among the two essential divisions of mother or father firm F. Hoffman-La Roche AG, a Swiss multinational healthcare firm that focuses on prescription drugs and diagnostics. Roche Diagnostics’ North American headquarters is positioned in Indianapolis, Indiana. The division leverages superior applied sciences to reinforce its world service choices, significantly in optimizing provide…
In healthcare, affected person information is the basis of analysis, therapy, and belief. With digital well being programs and AI instruments turning into central to care supply, healthcare suppliers accumulate exponentially extra delicate affected person information. This information explosion has additionally expanded the assault floor, with nations adopting totally different frameworks and approaches to managing…
This interview evaluation is sponsored by Clarivate and was written, edited, and revealed in alignment with our Emerj sponsored content guidelines. Learn extra about our thought management and content material creation providers on our Emerj Media Services page. Legal and mental property (IP) groups are going through mounting strain to transfer past conventional administrative features…
John Deere is a number one agricultural equipment and precision expertise firm devoted to advancing productiveness and sustainability in farming industries worldwide. The firm manufactures a complete vary of apparatus—spanning tractors, combines, and clever spraying options—serving producers of meals, gas, and infrastructure throughout the globe. In 2024, John Deere reported annual income of $51.7 billion…
Bayer is a worldwide life sciences firm working throughout Pharmaceuticals, Consumer Health, and Crop Science. In fiscal 2024, the group reported €46.6 billion in sales and 94,081 employees, a scale that makes inside AI deployments consequential for workflow change and ROI. The firm invests closely in analysis, with greater than €6 billion allotted to R&D…